Stocks · Health care · Biological Products, (No Diagnostic Substances)

Protalix BioTherapeutics, Inc.

PLX Clue Score38
United States Fiscal year ends December CIK 0001006281 Results filed 12 Aug 2026

What the insiders did No buying or selling

By person

9 insiders · 0 transactions
11.4×

Dror Bashan holds 11.4 times base salary in stock. $4.58M of shares against $401.84K in salary for 2025.

Salary from the company's own proxy. The shares are what Dror Bashan last reported holding, valued at $1.81, the price Common Stock was last bought or sold at on the open market here, on 19 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Dror Bashan
President and CEO
—
—
—
2,532,934
$4.58M
+11.0%
Aharon Schwartz
Director
—
—
—
310,500
$562.01K
+78.4%
Yaron Naos
Sr. VP & COO
—
—
—
225,817
$408.73K
+12.4%
Eliot Forster
Director
—
—
—
7,500
$13.58K
—
Amos Bar-Shalev
Director
—
—
—
7,500
$13.58K
+4,364%
Gwen A Melincoff
Director
—
—
—
7,500
$13.58K
—
Pol F Boudes
Director
—
—
—
7,500
$13.58K
—
Christian Elze
Director
—
—
—
7,500
$13.58K
—
Zvi Shmuel Ben
Director
—
—
—
7,500
$13.58K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.